Wehrheim

MGI Announces Commercial Launch of HotMPS High-Throughput Sequencing Kit* and Instrument** in Germany

Retrieved on: 
Tuesday, September 6, 2022

WEHRHEIM, Germany, Sept. 6,2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has announced the commercial availability of its innovative HotMPS reagents* and sequencing instrument** in Germany as of 9 August 2022.

Key Points: 
  • WEHRHEIM, Germany, Sept. 6,2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has announced the commercial availability of its innovative HotMPS reagents* and sequencing instrument** in Germany as of 9 August 2022.
  • Meanwhile, the DNBSEQ-G400** sequencing platform (for HotMPS exclusively) will be presented at MEDICA 2022 on 14-17 November in Dsseldorf.
  • MGI will also attend the 32nd GfH Annual Meeting on 15-17 March 2023 in Kassel as a sponsor.
  • "As our trusted partner, we are excited about MGI's HotMPS chemistry* arriving in Germany and the new research advances it will enable."